“What is the latest research telling us about men’s experience of cancer?”
When: 29th November 2016
What Time: 7pm - 8pm AEDT
Duration: 60 minutes
Where: Online - join via your computer, tablet or smart phone
Panel: Assoc Prof David Smith, Assoc Prof Peter Grimison and Phil Mendoza-Jones
About the Webinar
Celebrating Movember - Men like to know the ‘facts’, so we will be discussing the ‘facts’ surrounding everything about men and cancer – their prostate, relationships, sexuality and ongoing treatments
About the Presenters
This discussion will be facilitated by Jill Mills, Cancer Council NSW, Practical Support Unit and the panel will include:
Associate Professor David Smith
David is a Research Fellow and cancer epidemiologist at the Cancer Council NSW. He has a particular focus on prostate cancer, prostate cancer testing and prostate cancer outcomes in Australia.David works in the Health Services Research Program of the Cancer Research Division.He is chief investigator and project manager of the NSW Prostate Cancer Care and Outcomes Study (PCOS). This longitudinal study involving 2500 men examined quality of life after prostate cancer diagnosis along with PSA testing, coping styles, supportive care needs and the economics of prostate cancer management. In 2011 he obtained a National Health and Medical Research Council Post-Doctoral Research Fellowship to study the causes of death in men with prostate cancer. He is also currently chief investigator on two NHMRC project grants, one Prostate Cancer Foundation of Australia Grant and one partnership grant. A/Prof Smith has an adjuct position with Griffith University in QLD. See David's CV and publications here. Read more about the PCOS Study here.David Smith can comment on: issues to do with prostate cancer research and treatment issues, particularly the side effects of treatment, men and cancer.
Associate Professor Peter Grimison
Peter is currently Staff Specialist in Medical Oncology at the Chris O'Brien Lifehouse in Sydney; Visiting Medical Officer at Royal Prince Alfred and Dubbo Base Hospitals; and Clinical Associate Professor at the University of Sydney. His clinical work focuses on testicular cancer, other genito-urinary cancers, and upper gastro-intestinal cancers. He is involved as germ cell subcommittee chair, member of the scientific advisory committee, trial management committee member, and site principal investigator in several national and international trials for the Australian and New Zealand Urogenital and Prostate Cancer Trials Group, whose coordinating centre is based at the NHMRC Clinical Trials Centre of the University of Sydney. He is also involved as an active member and site Principal Investigator in clinical trials for the Australasian Gastro-Intestinal Trials Group; and site Principal Investigator for industry sponsors. He serves as a member of the Australian Government Pharmaceutical Benefits Advisory Committee, and a number of other Federal and NSW Government committees. He is also committed to teaching as coordinator of Advanced Training in Medical Oncology at the Chris O'Brien Lifehouse, and also actively teaches in Basic Physician Training and the University of Sydney Medical Program.
Phil had been operating his solo marketing and advertising consultancy for over ten years when diagnosed with colon cancer in October 2004. He endured a seven months precautionary chemotherapy treatment, which had debilitating effects on both his business as well as his obsession with fitness and sport.
After years of perseverance and patience, he is now back playing singles tennis twice a week and taking 12km walks three to four times a week. He’s still working too. It was a long road, but his approach to pain management won in the end.
The Cancer Council NSW is collecting the information in this form for the purpose of registering you for this webinar. If you do not provide the mandatory information, you may not be able to participate.
Cancer Council NSW may use your details to send you information which we consider may be of interest to you. You can opt out at any time.
Your information will be viewed by our third party service provider, Redback Conferencing, who are assisting Cancer Council to deliver this webinar.